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Research
Ofﬁcial ﬁgures for the prevalence and occur-
rence of drug abuse in different countries are
currently obtained from population surveys
integrated with crime statistics, medical
records, and drug production and seizure
rates [European Monitoring Centre for
Drugs and Drug Addiction (EMCDDA)
2006; United Nations Office of Drugs and
Crime (UNODC) 2007a]. These statistical
tools give a useful general picture of drug
abuse, but estimates of consumption rates
and drug use prevalence may be inaccurate, as
most of the information is obtained from the
consumers themselves. Moreover, because
data collection and analysis are time consum-
ing, current methods cannot offer frequently
updated results to quickly detect changing
patterns, and it is not easy to compare results
between local communities (EMCDDA
1997). As recently recommended by the
Commission of Narcotic Drugs of the
United Nations (UNODC 2007b), novel
approaches are needed not only to provide
more realistic and comparable estimates of
illicit drug consumption in different commu-
nities, but also to detect changes in drug
abuse patterns rapidly.
We tested a sewage epidemiology strategy
to monitor patterns and trends of commu-
nity-wide illicit drug use. The idea of using
drug monitoring at sewage treatment plants
(STPs) to assess collective drug consumption
was presented as a speculative proposal by
Daughton in 2001, and the methodologic
approach was devised and implemented by
our group using cocaine as a model drug in
2005 (Zuccato et al. 2005). Sophisticated ana-
lytical methods for measuring several drugs of
abuse have since been set up by us and others,
as reviewed by Castiglioni et al. (2008). 
Urban wastewater entering an STP is an
accessible, economical source of real-time,
pooled epidemiologic information (Bohannon
2007). Human metabolic waste products
that are rapidly collected and pooled by the
sewage systems can provide valuable evidence
of the amount and type of any common
product consumed by a population (Dove
2006). Earlier work with therapeutic drugs
has shown close correspondence between the
known amounts consumed by the popula-
tion and amounts estimated from concentra-
tions of metabolic drug residues measured in
wastewater (Heberer and Feldmann 2005;
Lindberg et al. 2005). If an excretion product
is stable in wastewater and efficiently con-
veyed to the STP, it is reasonable to assume
that the amount collectively excreted in a
given period should be reflected by the
amount reaching the STP in the correspond-
ing interval (Daughton 2001). Therefore, we
sought to provide objective, quantitative, near-
real-time proﬁles of illicit drug consumption
by monitoring selected drug residues entering
the municipal sewage system. To test this
approach, we chose a panel from among the
most-used illicit drugs worldwide (Table 1),
selecting their main excretion products as ana-
lytical targets for wastewater monitoring
(Castiglioni et al. 2006).
Materials and Methods
Drugs of abuse. Community-wide consump-
tion of common drugs of abuse, that is,
cocaine, heroin, cannabis, and amphetamine-
type drugs [amphetamine, methamphetamine,
ecstasy (3,4 methylenedioxymethampheta-
mine)] was estimated by analysis of selected
drug excretion residues in wastewater. 
Selection of drug target residues. The drug
residues targeted for wastewater measurement
and back-calculation of drug consumption are
referred to as drug target residues (DTR). An
ideal DTR is a major and exclusive excretion
product (metabolite or unchanged parent
drug) of the drug under study that is stable in
wastewater. The DTRs used for this study
(Table 1) were chosen by determining the
metabolic fate of each active drug in light of
current knowledge and then experimentally
determining the stability of candidate residues
in wastewater (Castiglioni et al. 2006). We
thus selected as DTRs the main urinary
metabolites for cocaine, heroin, and cannabis,
and the unchanged parent drug for the
amphetamines (Baselt 2004; Huestis et al.
1996; Maurer et al. 2006). Glucuronic
acid–conjugated metabolites, the most abun-
dant excretion products of heroin and
cannabis, had to be discounted as DTRs
because of their instability in wastewater.
Glucuronates are rapidly hydrolyzed back to
the corresponding free compound by fecal
bacterial enzymes (D’Ascenzo et al. 2003;
Ternes et al. 1999). Our stability studies
(Castiglioni et al. 2006) conﬁrmed that glu-
curonic acid–conjugated metabolites added to
wastewater rapidly disappear, releasing the free
compound. Therefore, the selected DTRs for
heroin and tetrahydrocannabinol (THC) were
free morphine and 11-nor-9-carboxy-Δ9-
tetrahydrocannabinol (THC-COOH).
Wastewater sampling. Composite samples
of untreated urban wastewater were collected
from the inlet of the STPs by sampling waste-
water every 20 min for 24 hr in a time-pro-
portional mode, then pooling the subsamples
with an automatic, computer-controlled
device. To test the reproducibility over time
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METHODS: Selected drug target residues derived from use of cocaine, opiates, cannabis, and
amphetamines were measured by mass spectrometry in wastewater collected at major sewage treat-
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of drug residues conveyed to the treatment plants, reﬂecting the amounts collectively excreted with
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RESULTS: Reproducible and characteristic profiles of illicit drug use were obtained in the three
cities, thus for the ﬁrst time quickly revealing changes in local consumption (e.g., cocaine consump-
tion rose signiﬁcantly on weekends in Milan). Proﬁles of local drug consumption based on waste-
water measurements are in line with national annual prevalence estimates.
CONCLUSIONS: Patterns and trends of drug abuse in local communities can be promptly monitored
by this tool, a convenient new complement to more complex, lengthy survey methods. In principle,
searching the sewage for excreted compounds relevant to public health issues appears to have the
potential to become a convenient source of real-time epidemiologic information.
KEY WORDS: amphetamines, cannabis, cocaine, drug residues, illicit drugs, mass spectrometry, opiates,
sewage epidemiology, urinary metabolites. Environ Health Perspect 116:1027–1032 (2008).
doi:10.1289/ehp.11022 available via http://dx.doi.org/ [Online 1 May 2008]of ﬁeld data from a given STP, samples were
taken on consecutive days for 1 week on three
different occasions in Milan, Italy (Nosedo
STP, sampled for 7 days in November 2005
and in February and March 2006; population
served, 1.25 million), and for 1 week in
Lugano, Switzerland (STP sampled for 7 days
in March 2006; population served, 0.12 mil-
lion). Measurements were also taken in
London, United Kingdom, at two major
plants (Mogden and Beckton STPs, sampled
for 2 days in October 2005; populations
served, 1.8 and 3.7 million).
Analysis of DTRs in wastewater. Illicit
drug residues (Table 1) were measured in
wastewater samples with a fully validated,
highly selective multiresidue assay described in
detail by Castiglioni et al. (2006). Briefly,
water samples were spiked with internal stan-
dards, acidiﬁed, and solid-phase extracted on
mixed reversed-phase/cation-exchange car-
tridges (Oasis-MCX; Waters Corp., Milford,
MA, USA), preconditioned with methanol,
water, and 0.01N HCl, then eluted with
methanol and 2% ammonia in methanol. The
pooled eluates were analyzed by liquid chro-
matography–tandem mass spectrometry using
an API 3000 triple quadrupole mass spec-
trometer, equipped with a turbo ion spray
source (Applied Biosystems–Sciex, Thornhill,
Ontario, Canada) interfaced to LC Series 200
pumps and an autosampler (Perkin-Elmer,
Norwalk, CT, USA). Drugs were analyzed
using an XTerra MS C18, 100 mm × 2.1 mm,
3.5-µm column (Waters Corp.) at a ﬂow rate
of 200 µL/min. Quantitative analyses were
done in the selected reaction monitoring
(SRM) mode, measuring the fragmentation
products of the protonated or deprotonated
pseudo-molecular ions of each compound and
deuterated analog. The recoveries, repeatabil-
ity, instrumental limits of detection (LODs),
and limits of quantification (LOQs) for the
entire method were calculated in wastewater
samples as described (Castiglioni et al. 2006).
From measured DTR concentrations to
collective DTR excretion rates. Using the
approach described for cocaine (Zuccato et al.
2005), the concentration (nanograms per liter)
of a given DTR in wastewater was multiplied
by the inﬂuent wastewater ﬂow rate (liters per
day) to calculate the amount of each DTR daily
reaching a given STP (grams per day). The data
were then normalized for the local population
size (number of people served by the STP).
Assuming no major loss of wastewater along the
sewage system and given the proven stability of
the chosen DTR in wastewater (Castiglioni
et al. 2006), these ﬁgures (milligrams per day
per 1,000 people) reasonably reﬂect the collec-
tive excretion rates for the various DTRs.
From DTR excretion rates to collective
drug consumption rates. The collective excre-
tion rate of a given DTR was used to extrapo-
late the amount of the active parent drug
consumed by the population under study. This
was done by correcting the amount of each
excreted DTR by a factor (Table 1), taking
into account the known fraction of the con-
sumed parent drug normally excreted as DTR
in urine, and the parent drug-to-DTR molar
mass ratio (Table 1). For example, about 45%
of intranasal cocaine (molecular weight 303) is
excreted in urine as benzoylecgonine (BE; mol-
ecular weight 289), so a measured BE excretion
rate of 100 mg/day/1,000 people corresponds
to 100/0.45 × 303/289 = 233 mg of cocaine
consumed per day per 1,000 people. 
These calculations are valid when a DTR is
a main specific excretion product of a single
parent drug and therefore a reliable direct indi-
cator of consumption. This applies to all the
DTRs used here except morphine, a residue
not excreted solely after intake of heroin, but
after morphine and codeine as well. The frac-
tion of wastewater morphine originating from
consumed codeine was considered negligible,
as morphine is a minor metabolite of codeine
(Baselt 2004). When back-calculating heroin
consumption based on wastewater morphine,
corrections were therefore applied only to com-
pensate for the obviously substantial contribu-
tion from therapeutic morphine (Ther-M).
Brieﬂy, we ﬁrst considered the known average
consumption of Ther-M in Italy, Switzerland,
and the United Kingdom: 11, 82, and 123 mg
morphine/day/1,000 people, respectively
(Zuccaro et al. 2006). The daily amounts of
Zuccato et al.
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Figure 1. Average daily amounts (mean ± SD, g/day, n = 3) of illicit drug residues conveyed by wastewater
to Milan’s STP (1.25 million people served). Levels of amphetamines were near or below the LOD based on
available data (2-week period). To allow a rough comparison with the proﬁles of the other, more abundant
drugs, undetectable levels were considered 50% of the limit of quantiﬁcation (LOQ; typically around 1 ng/L
in wastewater). 
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Table 1. Analytical targets (DTR) selected for illicit drug monitoring in wastewater. 
Percentage of drug Molar mass ratio Correction
Drug DTR Relation of DTR to parent drug dose excreted as DTRa (parent drug/DTR) factor
Cocaine BE Major  metabolite 45 1.05 2.33
Cocaine Parent drug (minor excretion product)
Heroin Morphine Major but nonexclusive metabolite 42 1.29 3.07
6-Acetylmorphine Minor but exclusive metabolite
Amphetamines
Amphetamine Amphetamine Parent drug and major excretion product 30 1.0 3.3
Methamphetamine Methamphetamine  Parent drug and major excretion product 43 1.0 2.3
Ecstasy  Ecstasy  Parent drug and major excretion product 65 1.0 1.5
Cannabis THC-COOH Major metabolite of THC 0.6 0.91 152
(cannabis active principle)
Levels of DTRs were used for back-calculating drug consumption; the correction factor takes into account the percentage of parent drug excreted as the chosen DTR, and the parent
drug-to-DTR molar mass ratio.
aAverage for the most frequent route of intake.wastewater morphine expected to originate
from Ther-M, back-calculated from these ﬁg-
ures, were then subtracted from the total daily
amounts of wastewater morphine. The
remaining wastewater morphine was assumed
to originate mostly from heroin. 
From drug consumption rates to the num-
ber of doses consumed. To compare our esti-
mates of collective drug consumption with
official figures that mainly refer to drug use
prevalence, we had to translate total consumed
amounts of parent drugs into the correspond-
ing number of average consumption units (i.e.,
doses), as defined by official statistics. The
actual amount of pure drug in a consumption
unit is not easily determined because drugs of
abuse can be taken by various routes in
amounts that vary widely among different con-
sumer groups and in different phases of an
individual’s history of use (Cohen and Sas
1994). In addition, the purity of street prod-
ucts ﬂuctuates unpredictably with time and in
different locations, leading to possible miscal-
culation of the actual average amounts of active
drug taken as a dose. Despite these limitations,
however, for each drug we established a best-
approximation average dose on the basis of the
literature and official statistics. The average
content of pure active drug in a typical dose
taken by the most common route (UNODC
2004) was assumed here to be approximately
100 mg for intranasal cocaine, 30 mg for oral
amphetamine and methamphetamine, 100 mg
for oral ecstasy, 30 mg for intravenous heroin,
and 125 mg for smoked THC (based on 
high-potency cannabis: 14% THC in hashish/
marijuana). The number of doses consumed
daily in the three cities was then calculated by
dividing drug consumption rates (milligrams
per day per 1,000 people) by these amounts of
active principle in an average dose.
Results
DTR excretion data as objective indices of
drug consumption. The total daily amounts of
DTRs reaching an STP directly reflect the
collective excretion of these residues by an
undetermined number of drug consumers in
the population served by that plant. Figure 1
shows the average daily amounts of DTRs
reaching Milan’s STP, serving 1.25 million
people. On average, about 0.5 kg BE (a major
cocaine metabolite), 200 g cocaine, 40 g mor-
phine (in part derived from heroin), 25 g
THC-COOH (main residue from cannabis),
and a few grams of amphetamines reached the
plant every day. When DTR excretion rates
are normalized for the number of people
served by the plant (milligrams per day per
1,000 people), they can be compared between
different communities (Tables 2 and 3).
Reproducibility of DTR excretion data.
From the repeated weekly surveys in Milan,
the average daily collective DTR excretion
rates appeared reproducible, for major, steadily
detectable DTRs, between different days and
weeks [relative standard deviation (RSD)
< 16% over 7 days and < 19% over 3 weeks for
BE, THC-COOH, and morphine] (Table 4).
When replicate data grouped according to the
day of the week were analyzed by one-way
ANOVA, collective excretion of most DTRs
appeared generally steady over time, with a sig-
niﬁcant peak of BE from cocaine on Saturdays
(p < 0.01 vs. Monday, p < 0.02 vs. Tuesday or
Wednesday, Dunnett’s test). There was a non-
signiﬁcant increase during the weekend for the
amphetamines. Morphine and THC-COOH
remained constant during the week (Figure 1),
suggesting steady use of heroin and cannabis in
Milan. Variation was also limited for most
major DTRs in Lugano and London as well
(Table 2).
Estimated illicit drug consumption.
Further processing of DTR excretion data
allowed us to back-calculate consumption
rates (milligrams per day per 1,000 people) for
the illicit drugs, as described in “Materials and
Methods” and Table 1. Results for the three
cities (Figure 2) show similarity in the con-
sumption profiles of cannabis, cocaine, and
heroin (THC >> cocaine > heroin). Our data
suggest that people in Milan tend to consume
slightly more cocaine and less cannabis than
people in Lugano and London (Tables 2
and 3).
For the amphetamine-type drugs, the pic-
ture was more complex and harder to interpret
because their residues in wastewater were gen-
erally low and often undetectable, in line with
recent ﬁndings in Spain (Huerta-Fontela et al.
2007). Nevertheless, it was evident that
amphetamine consumption was much higher
in London than in Milan, despite similar
methamphetamine use in these cities. The use
of ecstasy, the only amphetamine-type drug
detected in Lugano, did not differ substantially
in the three cities.
Estimated heroin consumption. With all
the caveats regarding the use of morphine as a
DRT for heroin, we ﬁrst assessed whether the
contribution of heroin use to wastewater mor-
phine was indeed substantial. We therefore
additionally monitored a minor (possibly ﬂuc-
tuating) but exclusive metabolite of heroin,
6-acetylmorphine. The presence of 6-acetyl-
morphine in the wastewater samples from
Estimating community drug abuse by wastewater analysis
Environmental Health Perspectives • VOLUME 116 | NUMBER 8 | August 2008 1029
Table 4. Variation in collective excretion rates (mean ± SD, g/day) of major DTRs between days (RSD for the average of seven daily means) and between weeks
(RSD for the average of three weekly means) in Milan.
Collective excretion of DTR (g/day) 
Average of Average of  Between-days Between-weeks
Monday Tuesday Wednesday Thursday Friday Saturday Sunday daily means weekly means variation variation
DTR (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) (n = 3) (n = 7) (n = 3) (RSD, %) (RSD, %)
BE 326 ± 47 334 ± 41 338 ± 35 407 ± 7 409 ± 80 522 ± 111 394 ± 60 390 ± 63 390 ± 39 16 10
Cocaine 153 ± 49 158 ± 104 157 ± 93 136 ± 51 155 ± 70 188 ± 94 155 ± 65 157 ± 14 157 ± 74 9 47
Morphine 31 ± 9 37 ± 11 31 ± 3 34 ± 5 29 ± 7 33 ± 10 31 ± 12 32 ± 2 32 ± 6 8 19
THC-COOH 21 ± 1 20 ± 4 18 ± 3 22 ± 3 19 ± 3 21 ± 5 18 ± 2 20 ± 1 20 ± 2 7 11
Table 2. Amounts (mg/day/1,000 people) of major DTRs from illicit drug consumption conveyed daily in
urban wastewater to STPs in Milan, Lugano, and London. 
DTR Milan Lugano London (Mogden; Becton)a
BE  390 ± 63 267 ± 52 296 ± 18 (302; 290)
Cocaine 157 ± 14 109 ± 23 140 ± 10 (141; 139)
Morphine 32 ± 3 102 ± 15 173 ± 29 (196; 150)
THC-COOH 20 ± 2 43 ± 10 50 ± 21 (56; 44)
Values reﬂect collective DTR excretion rates. Data are mean ± SD of daily samplings for 1 week and 3 nonconsecutive
weeks at Milan STP (n = 21), and for 1 week at Lugano STP (n = 7). Two London STPs were sampled for 2 days, on
Thursday and Friday (n = 4). 
aValues in parentheses represent averages for Mogden and Beckton STPs, respectively.
Table 3. Amounts (mg/day/1,000 people) of DTRs from amphetamine-type drugs conveyed daily in urban
wastewater to STPs in Milan, Lugano, and London.
DTR Milana  Lugano London
Amphetamine 2.7 ± 2.8 (5/14) ND (0/7) 24 ± 5 (4/4)
Methamphetamine 4.5 ± 1.6 (14/14) ND (0/7) 2.4 ± 0.3 (4/4)
Ecstasy  4.2 ± 3.7 (12/14) 7.3 ± 5.1 (7/7) 3.4 ± 1.0 (4/4)
ND, not detectable. Values in parentheses represent the number of positive/total samples. Data are mean ± SD, with val-
ues for negative samples averaged as half the LOQ. 
aData for amphetamine-type drugs were available for 2 weeks from Milan.Milan and Lugano, at levels that averaged
about 5% of measured morphine (data not
shown), proved that heroin steadily contributes
to wastewater morphine. The estimates of
heroin consumption shown here (Figures 2
and 3) for Milan, Lugano, and London were
then back-calculated from total wastewater
morphine, after subtracting the fraction pre-
sumably originating from local therapeutic use
of morphine (Table 5). Wastewater morphine
from heroin consumption accounted for about
70, 30, and 40% in Milan, Lugano, and
London, respectively. Accurate, updated infor-
mation about local morphine use should there-
fore be considered in future studies to reﬁne
the assessment of actual heroin consumption.
Comparison of wastewater-derived data
with ofﬁcial statistics. We next veriﬁed whether
our estimates were in line with official
epidemiologic data describing the drug abuse
phenomenon. We compared local proﬁles of
illicit drug use (deﬁned as number of doses per
day per 1,000 people), obtained from measure-
ment of drug residues in wastewater, with
national proﬁles of drug use (deﬁned as the per-
centages of users among persons 15–64 years of
age) obtained from annual prevalence data in
the countries under study. Despite the limita-
tions arising from the necessary assumptions in
defining average consumption units (i.e.,
doses), our approach gave local drug use pro-
ﬁles (Figure 3A) in line with patterns of drug
use based on national annual prevalence data
(Figure 3B) (UNODC 2006), except for
amphetamine-type drugs. 
Discussion
Our evidence-based approach for monitoring
collective illicit drug use gave reproducible and
comparable proﬁles. Repeated weekly monitor-
ing of DTRs of Milan STP on different occa-
sions showed that the method can detect
significant fluctuations in consumption that
consistently occur during a week, such as the
rise in cocaine use toward the weekend
(Figure 1). As expected, drugs that tend to be
consumed steadily, such as cannabis, have stable
DTR excretion along the week, with only small
variations on different occasions (Figure 1).
Comparison of DTR excretion data from
Milano, Lugano, and London (Table 2)
offered direct evidence that the three proﬁles
of drug use have many similarities and a few
local peculiarities in line with local drug use
habits, for example, high amphetamine con-
sumption in the United Kingdom (UNODC
2007a, 2007b). These findings suggest that
wastewater measurements provide objective,
direct evidence of collective DTR excretion
that can be used to compare patterns of illicit
drug use in different communities.
Our drug use profiles (number of daily
doses per 1,000 people) agree with official
annual prevalence figures in indicating that
the drug most used by far is cannabis
(Figure 3). The relative importance of cocaine
and heroin use is similarly represented by the
two methods. However, our use proﬁles, but
not prevalence estimates, suggest that amphet-
amines (including ecstasy) are the drugs least
used in all locations (Figure 3). A possible rea-
son may lie in the intrinsic differences in the
two approaches. Our sewage approach offers
direct evidence of relative consumption rates,
but no indication about the number of users.
Prevalence figures, on the other hand, focus
on the number of users, often without speciﬁc
reference to use patterns (e.g., number of
doses per month, occasional or continuous
use) or the amounts consumed (e.g., size of
personal doses). As the number of users is gen-
erally defined as the percentage of people
(often within speciﬁc age groups) who admit
having used a drug in a given interval (e.g., the
last month), prevalence data may tend to over-
estimate the use of drugs that are used occa-
sionally by many (e.g., the amphetamines)
rather than used steadily by a few.
Despite this latter limitation, we tried to
assess how our approach compared with ofﬁcial
data in terms of number of doses used in these
populations. For example, for cocaine, national
prevalence ﬁgures (EMCDDA 2006) indicate
that in Italy 1.2% of adults (15–64 years of
age)—about 10,000 people in Milan—used the
drug during the last year. If these people were
all light users of cocaine (consuming, on aver-
age, 16 g/person/year) (Caulkins et al. 1999),
they would collectively consume about
160 kg/year. Our figures, however, provide
Zuccato et al.
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Table 5. Back-calculation of heroin consumption (mg/day/1,000 people) in Milan, Lugano, and London after
correcting for the contribution of therapeutic morphine to the overall amount of wastewater morphine.
Milan Lugano London
Therapeutic morphine consumptiona 11 82 123
Estimated excretion of Ther-Mb 9 70 105
Total-M 32 102 173
Heroin-derived morphine  23 32 68
Back-calculated heroin consumption 70 100 210
Total-M, total morphine measured in wastewater. Heroin-derived morphine = Total-M – Ther-M.
aBased on yearly consumption of morphine in Italy, Switzerland, and United Kingdom of 4, 30, and 45 mg per capita per year
(Zuccaro et al. 2006). bBack-calculated from consumption rates, taking into account the DTR fractional excretion (85%). 
Figure 2. Estimated consumption rates (mean ± SD, mg/day/1,000 people) of illicit drugs in Milan, Lugano,
and London, back-calculated from DTR excretion rates after correction for the factors shown in Table 1.
Estimates for amphetamine-type drugs are shown only where DTR levels were measurable (in > 85% sam-
ples). Estimates of heroin consumption were back-calculated after subtracting the fraction of wastewater
morphine presumably excreted as a product of therapeutic morphine, as expected from the known mor-
phine consumption in the three countries.
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Figure 3. Comparison of local proﬁles of illicit drug use (mean ± SD, doses/day/1,000 people) obtained from
drug residues in wastewater and national proﬁles of drug use (deﬁned as the percentage of users among
persons 15–64 years of age) based on annual prevalence data in the countries under study. (A) Data
derived from estimated drug consumption rates (Figure 2) divided by the amount of the active drug in a
typical dose. Values for amphetamine/ecstasy that are barely visible are 0.42 ± 0.18, 0.11 ± 0.08, and 2.9 ±
0.2 doses/day/1,000 people in Milan, Lugano, and London, respectively. (B) Data from the UNODC (2006).
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Cannibisdirect evidence that about 330 kg of cocaine are
used in the city each year, suggesting that the
actual amount consumed by the predicted users
in Milan is higher than the light use standard. If
most cocaine consumers in Milan were light
users, more people would be involved than
expected from national prevalence ﬁgures. This
example suggests that our estimates compare
reasonably with ofﬁcial ﬁgures, while offering
sound evidence of overall drug consumption
that could be used to reﬁne and integrate ofﬁ-
cial statistics, especially at the local level.
Our sewage approach to drug consump-
tion monitoring has three main advantages.
The first, and most important, is the use of
objective, quantifiable measures (i.e., DTR
concentration, wastewater flow rate, popula-
tion size) providing realistic and reproducible
pictures of the amount and type of illicit
drugs consumed in different communities
(Table 6). Another point is that these results
can be obtained in near real time, because
wastewater drug profiling by multiresidue
mass spectrometric analysis can be completed
in 1 or 2 days after sampling. The third bene-
fit comes from the possibility of integrating
wastewater data with other information on
illicit drug use (e.g., metabolism/kinetics,
average doses, purity of street products) to
reﬁne the estimates of drug consumption and
improve comparability of drug use profiles.
This data integration is only feasible by deﬁn-
ing assumptions based on best current knowl-
edge (Table 6).
Given that this is a newly implemented
approach, we offer our critical view of the
Estimating community drug abuse by wastewater analysis
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Table 6. Characteristics, advantages, and potential limitations of the “sewage approach” for monitoring illicit drug consumption.
Possible bias
Estimated inaccuracy Action to improve accuracy
Measurements Type of data Reliability of data Source of bias Probability of occurrence (this study) (future large-scale studies)
Excretion of DTR  Concentration of Potentially very Possible adsorption Low Probably negligible Monitoring multiple DTR
(mg/day/1,000 DTR in reliable (if validated, of some DTR to for each drug
people) wastewater (ng/L) highly speciﬁc particulate Speciﬁc studies on DTR
analytical methods  partition between water
are used) and particulate
Wastewater ﬂow  Normally well Leakage from sewers Low Probably low Wastewater ﬂow strictly
into STP (L/day) controlled (in  of substantial controlled at STP, sewer
modern STP) wastewater leakage checked by 
dilution tests 
Population size (no. Likely reliable Fluctuating number of Low to medium (depending Probably low (as proven Actual number of people at
of people served  (variations reﬂected people in the  on type of community) by low variation over any time in the catchment
by STP) by water consumption catchment area time of collective area monitored/controlled
changes) (inhabitants, commuters, excretion rates for by various indicators (e.g.,
tourists, etc.) some DTR) other human by-products
in wastewater, energy 
consumption)
Possible bias
Type of Related Source of Probability of Estimated inaccuracy Action to improve accuracy
Estimates information assumptions information Source of bias occurrence (this study) (future large-scale studies)
Drug consumption  Total fraction (%)  a. Deﬁnition of a. Current literature a. Limited number a. Low to  a. Probably low for a. Further studies on
rate (mg/day/ of a drug dose correction factors on human drug of subjects in medium absolute rate of metabolism/kinetics for
1,000 people) excreted as DTR (Table 1) based on metabolism/kinetics most studies (depending  consumption if drugs of abuse (larger
(used to back- best available  on drug main speciﬁc number of subjects,
calculate amount  current knowledge under study) metabolite is chosen different consumption
of drug consumed  b. Wastewater used b–c. Previous studies No effect on routes and use patterns).
from amount of  as a surrogate  on therapeutic  comparability of Meta-analysis of all
excreted DTR) pooled urine sample  drugs showing  drug use proﬁle available metabolism/
from local population correspondence between locations kinetics studies
c. Wastewater (24-hr  between known drug over time at
sample) reﬂects near  consumption and given location
steady-state excretion  back-calculated
rate of drug residues  consumption (from
when wastewater DTRs)
1. STP serves large 
population (> 105
peoplea) 
2. No signiﬁcant 
ﬂuctuation in drug 
use simultaneously 
in a large proportion 
of users
Number of doses Amount of active Deﬁnition of best National/international a. Local differences a. Variable a. Can affect overall a. Local differences in drug
consumed (no. drug in a typical approximated typical drug agencies, ofﬁcial in drug market estimates of number market controllable by
of doses/day/ dose (used to  dose from available reports on drug  of doses but not analysis of drugs seized
1,000 people) back-calculate data abuse, scientiﬁc  consumption rates
number of doses  literature b. Differences in  b. Variable b. Can affect b. Mathematical modeling
from amounts  drug intake route estimated size of  to account for different
consumed) (intranasal, typical dose and  patterns of drug intake
smoke, ingestion, fraction of drug (from consumer
injection) dose excreted  interviews)
as DTR 
c. Different habits  c. Variable c. Can affect  c. Mathematical modeling
(light vs. heavy; estimated size of  to account for drug use
regular vs.  typical dose habits (from consumer
occasional use) interviews)
aTentative estimate to be investigated in ad hoc studies.Zuccato et al.
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potential biases in Table 6 and list a number of
actions that may be taken in future studies to
improve the accuracy of the calculations and
assumptions used here. A multifaceted critical
assessment seems desirable with a view to
improving the current approach on the basis
of joint expertise from researchers, local
authorities, and international drug agencies.
Concerted actions could be aimed in particular
at a) locally controlling parameters in the sewer
system and population size ﬂuctuations in the
STP catchment area; b) integrating collective
consumption data with updated statistics on
local drug use patterns for each drug (e.g.,
intake routes, frequency of use, size of typical
dose); and c) reﬁning the assumptions related
to metabolism/kinetics of the various drugs by
further experimental work and mathematical
modeling. Considering that our ﬁrst unreﬁned
approach to monitoring cocaine use by waste-
water analysis (Zuccato et al. 2005) is already
being applied in different countries, including
the United States (Bohannon 2007; Bones
et al. 2007), a consensus view appears essential
for the comparability of future studies.
In conclusion, testing wastewater for illicit
drug residues provides objective ﬁeld data that
can offer a reliable picture of collective drug
residue excretion in a large community. Data
can be further elaborated with quantitative
assumptions to estimate the consumption of
the active principle for the various drugs and
the overall number of daily doses consumed.
The sewage epidemiology approach to drug
consumption monitoring could be used
prospectively for a) using updated drug proﬁle
analyses to rapidly identify emerging hot spots
of drug abuse; b) testing in real time the efﬁcacy
of different countermeasures such as prevention
through education, enforcement, and global
concerted actions against illicit drug consump-
tion; c) cross-validation of population surveys
versus wastewater monitoring programs; and
d) assessing the actual amount of illegal money
involved in drug trafﬁcking.
If applied to other public health issues,
this approach has the potential to extract use-
ful epidemiologic data from qualitative and
quantitative proﬁling of biological indicators
entering the sewage system.
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